Perspective Therapeutics (CATX)
Develops image-guided lead-212 cancer therapies with paired lead-203 imaging.
$3.01
After hours+0.05 (+1.86%)
At close$2.96(−0.51%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
estimated · in 48 days
EPS estimate
−$0.24
Revenue estimate
$62.1K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.57−$0.25−$0.30−$0.35−$0.51−$0.25−$0.22Pending
Estimate−$0.26−$0.28−$0.30−$0.33−$0.37−$0.29−$0.25−$0.24
Surprise−119.2%+10.7%0.0%−6.1%−37.8%+13.8%+12.4%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$234.0K$342.0K$290.0K$209.0K$43.0K$76.0K$81.0KPending
Estimate$277.3K$142.5K$204.4K$244.4K$232.5K$157.4K$90.5K$62.1K
Surprise−15.6%+139.9%+41.8%−14.5%−81.5%−51.7%−10.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.29 | — | — |
| Sep 2027 | −$0.26 | — | — |
| Jun 2027 | −$0.26 | — | — |
| Mar 2027 | −$0.25 | — | — |
| Dec 2026 | −$0.26 | — | — |
| Nov 2026 | −$0.24 | — | — |
| Aug 2026 | −$0.25 | −$0.22 | +12.4% |
| May 2026 | −$0.29 | −$0.25 | +13.8% |
| Mar 2026 | −$0.37 | −$0.51 | −37.8% |
| Nov 2025 | −$0.33 | −$0.35 | −6.1% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Sep 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Sep 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Sep 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Sep 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Sep 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Sep 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.29 | — | — | $25.0K | — | — | — |
| Sep 2027 | −$0.26 | — | — | $80.0K | — | — | — |
| Jun 2027 | −$0.26 | — | — | $80.0K | — | — | — |
| Mar 2027 | −$0.25 | — | — | $140.0K | — | — | — |
| Dec 2026 | −$0.26 | — | — | $67.1K | — | — | — |
| Nov 9, 2026 | −$0.24 | — | — | $62.1K | — | — | — |
| Aug 10, 2026 | −$0.25 | −$0.22 | +12.4% | $90.5K | $81.0K | −10.5% | +6.0% |
| May 11, 2026 | −$0.29 | −$0.25 | +13.8% | $157.4K | $76.0K | −51.7% | +3.2% |
| Mar 16, 2026 | −$0.37 | −$0.51 | −37.8% | $232.5K | $43.0K | −81.5% | +4.4% |
| Nov 10, 2025 | −$0.33 | −$0.35 | −6.1% | $244.4K | $209.0K | −14.5% | 0.0% |
| Aug 13, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 26, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 11, 2023 | |||||||
| May 15, 2023 | |||||||
| Feb 16, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Sep 28, 2022 | |||||||
| May 10, 2022 | |||||||
| Feb 8, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Sep 21, 2021 | |||||||
| May 13, 2021 | |||||||
| Feb 9, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Sep 17, 2020 | |||||||
| May 12, 2020 | |||||||
| Feb 11, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Sep 24, 2019 | |||||||
| May 9, 2019 | |||||||
| Feb 12, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Sep 25, 2018 | |||||||
| May 3, 2018 | |||||||
| Feb 8, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Sep 28, 2017 | |||||||
| May 10, 2017 | |||||||
| Feb 8, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Sep 8, 2016 | |||||||
| May 10, 2016 | |||||||
| Feb 9, 2016 | |||||||
| Nov 9, 2015 | |||||||
| Sep 14, 2015 |